Integrated Assessment of Intestinal Barrier Function and Microscopic Inflammation Using Confocal Laser Endomicroscopy
Horia Minea1,2, Catalin Sfarti1,2,3, Stefan Chiriac1,2
1Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Probe-based confocal laser endomicroscopy (pCLE) can predict ulcerative colitis relapse by assessing mucosal healing. Patients with intact intestinal barrier and no inflammation showed no relapse, indicating pCLE
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Medical Imaging and Diagnostics
Background:
- Current ulcerative colitis (UC) management targets endoscopic healing, but microscopic inflammation and barrier dysfunction increase relapse risk.
- Identifying patients at high risk for relapse is crucial for optimizing UC treatment strategies.
Purpose of the Study:
- To evaluate if probe-based confocal laser endomicroscopy (pCLE) can identify structural and functional mucosal abnormalities predicting loss of therapeutic targets in UC.
- To assess the prognostic value of pCLE in predicting clinical and endoscopic relapse in UC patients.
Main Methods:
- Prospective single-center study of 81 UC patients in clinical and endoscopic remission over 24 months.
- Baseline assessment included colonoscopy with pCLE and biopsies for histological inflammation (HI) and barrier dysfunction in the ileum and colon.
- Clinical evaluations were conducted every 3 months.
Main Results:
- Altered colonic permeability (OR=3.85) and pCLE-detected HI (OR=6.04) predicted loss of endoscopic remission.
- Altered ileal (HR=6.01) or colonic (HR=6.51) barrier function increased clinical relapse risk.
- Triple healing (histological healing, intact ileal and colonic permeability) at baseline predicted no relapse.
Conclusions:
- pCLE provides superior prognostic value for predicting UC relapse compared to standard assessments.
- Morphological and functional evaluation via pCLE may serve as a therapeutic target for preventing UC relapses.
- Achieving triple healing is associated with sustained remission in UC patients.
More Related Videos
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
07:32An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
